We found that both rhTRAIL and UC-MSC secreted TRAIL could inhibit B-ALL cells proliferation in vitro and in vivo, while UC-MSCs secreted TRAIL exhibited longer serum half-life in vivo. Here, TNFSF10 is linked to precursor B-cell acute lymphoblastic leukemia.